Patents by Inventor Kartik Kiran Shah

Kartik Kiran Shah has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20200261541
    Abstract: The present disclosure provides methods for treating mild brain injury and other neurological disorders in a subject in need thereof, comprising administering to the subject an effective amount of a compound comprising a ghrelin or ghrelin variant.
    Type: Application
    Filed: November 1, 2019
    Publication date: August 20, 2020
    Applicant: Oxeia Biopharmaceuticals, Inc.
    Inventors: Kartik Kiran Shah, Amit Dilip Munshi
  • Publication number: 20180071367
    Abstract: The present disclosure provides methods for treating one or more of cognitive deficits or cognitive impairments associated with or caused by mild brain injuries, chemotherapy treatment, chemotherapy medication, post-chemotherapy cognitive impairment (PCCI), chemo brain, and other disorders arising from cognitive dysfunction in a subject by administering to the subject an effective amount of a composition comprising ghrelin or a ghrelin variant.
    Type: Application
    Filed: March 8, 2016
    Publication date: March 15, 2018
    Applicant: Oxeia Biopharmaceuticals, Inc.
    Inventors: Kartik Kiran SHAH, Amit Dilip MUNSHI, Reema BATRA
  • Publication number: 20170281732
    Abstract: The present disclosure provides methods for treating mild brain injury and other neurological disorders in a subject in need thereof, comprising administering to the subject an effective amount of a compound comprising a ghrelin or ghrelin variant. This invention provides for methods for treating a mild brain injury or concussion in a patient wherein said method comprises administering to the subject in need thereof suffering from said mild brain injury or concussion an effective amount of a ghrelin variant or a composition comprising a ghrelin variant so as to treat said mild brain injury or concussion.
    Type: Application
    Filed: August 18, 2015
    Publication date: October 5, 2017
    Applicant: Oxeia Biopharmaceuticals, Inc.
    Inventors: Kartik Kiran Shah, Amit Dilip Munshi
  • Publication number: 20170266257
    Abstract: The present disclosure provides methods for treating traumatic brain injury and other neurological disorders in a subject in need thereof, comprising administering to the subject an effective amount of a composition comprising ghrelin or a ghrelin variant. This invention provides for methods for treating a severe or moderate traumatic brain injury in a patient wherein said method comprises administering to the subject suffering from said severe or moderate traumatic brain injury a therapeutic effective amount of ghrelin or a ghrelin variant or a composition comprising ghrelin or a ghrelin variant so as to treat said severe or moderate traumatic brain injury.
    Type: Application
    Filed: August 18, 2015
    Publication date: September 21, 2017
    Applicant: Oxeia Biopharmaceuticals, Inc.
    Inventors: Kartik Kiran SHAH, Amit Dilip MUNSHI
  • Publication number: 20170121385
    Abstract: The present disclosure provides methods for treating a neurodegenerative condition or situation in a subject in need thereof, comprising administering to the subject an effective amount of a compound comprising ghrelin or a ghrelin variant.
    Type: Application
    Filed: October 28, 2016
    Publication date: May 4, 2017
    Applicant: Oxeia Biopharmaceuticals, Inc.
    Inventors: Kartik Kiran Shah, Amit Dilip Munshi